J&J’s DePuy Synthes launches Velys surgical robot for spine

Johnson & Johnson’s (NYSE: JNJ)+ DePuy Synthes announced today that it launched a dual-use robotics and standalone navigation platform that uses its Velys robot in spine surgery.

This marks the latest development for Velys, J&J’s robotic orthopedic surgery system that won its first FDA clearance for total knee surgery in 2021.  In June, Velys won FDA clearance for unicompartmental knee arthroplasty.

The medtech giant’s orthopedics unit developed the spine surgery Velys system in collaboration with eCential Robotics. eCential announced FDA 510(k) clearance for this platform last month. The companies designed the Velys active robotic-assisted system (Velys Spine) for planning and instrumenting spinal fusion procedures. Areas include the cervical, thoracolumbar and sacroiliac spine.

Sign up for Blog Updates